Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/26115
Tipo de Documento: Artigo
Título: Adverse drug reactions in high-risk pregnant women: a prospective study
Autor(es): Oliveira Filho, Alfredo Dias de
Vieira, Antonio Emanuel Soares
Silva, Roberta Cruz da
Neves, Sabrina Joany Felizardo
Gama, Thiago Antonio Barros
Lima, Ryane Vieira
Oliveira, Wlisses Ramon
Dias, Júlia Maria de Gonçalves
Data do documento: 2017
Resumo: Background: Because pregnant women are often excluded from clinical trials, there is still very limited information about the risk and safety of prescription drugs during pregnancy. Objective: We aimed to determine the prevalence of Adverse Drug Reactions (ADRs) in high-risk pregnant women after hospital admission. A prospective study was carried out in a teaching maternity hospital in Brazil during six months. Causality of ADRs was assessed through the Naranjo Algorithm and Korean Algorithm for ADR Causality Assessment. Severity of ADRs was assessed using Hartwig’s Severity Assessment Scale. Results: The prevalence of ADRs among the 294 inpatients studied was 8.8%. The mean age was 27.14 (±7.5) y.o. Patient’s age was related to the presence of ADRs, while the manifestation of these events was not associated with any adverse pregnancy outcome. 75.9% of the ADRs reported in the study were of mild severity and 24.1% were of moderate severity. No ADR was caused by drug-drug interaction; however, a significant increase in blood pressure was observed in all patients using concurrent methyldopa and ferrous sulfate. Conclusion: Overall, ADRs were not common events among high-risk pregnant women and no adverse pregnancy outcomes following these events were observed.
Palavras-chave: Adverse drug reactions
High-risk pregnancy
Prevalence
Maternal age
Methyldopa
Ferrous sulfate
Drug-drug interactions
ISSN: 2213-7475
Parte de : Saudi Pharmaceutical Journal
Idioma: eng
Instituição/Editora: Elsevier
Citação: OLIVEIRA FILHO, A. D. et al. Adverse drug reactions in high-risk pregnant women: a prospective study. Saudi Pharmaceutical Journal, Amsterdam, v. 25, n. 7, p. 1073–1077, 2017. DOI: http://dx.doi.org/10.1016/j.jsps.2017.01.005. Disponível em: https://www.sciencedirect.com/science/article/pii/S1319016417300191?via%3Dihub. Acesso em: 15 set. 2026.
Licença: Creative Commons Atribuição-Não Comercial-Sem Derivações 4.0 Internacional (CC BY-NC-ND 4.0)
Identificador: http://dx.doi.org/10.1016/j.jsps.2017.01.005
URI: https://ri.ufs.br/jspui/handle/riufs/26115
Aparece nas coleções:DME - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
AdverseDrugREactionHighRiskPregnantWomen.pdf395,04 kBAdobe PDFThumbnail
Visualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.